Stock News - Mineralys Therapeutics, Inc. $MLYS

Latest Stock News for $MLYS
Mineralys Therapeutics Reports Strong Q4 2025 Results and NDA Acceptance for Lorundrostat

Expected Stock impact: Noticeably Positive
2026-03-12 20:17:16